logo
Plus   Neg
Share
Email

BP Releases Energy Outlook

British energy giant BP Plc (BP.L,BP_UN.TO,BP) Tuesday said it expects fast growth in developing economies to drive up global energy demand a third higher.

The company released the 2018 edition of BP's Energy Outlook.

Moving ahead, the oil giant said it expects the global energy mix to be the most diverse the world has ever seen by 2040, with oil, gas, coal and non-fossil fuels each contributing around a quarter. Renewables are expected to the fastest-growing fuel source, increasing five-fold and providing around 14% of primary energy.

"BP's strategy has to be resilient and adaptable to significant changes in the energy industry. This Outlook considers the possible implications of some of these changes and helps inform our long-term planning. We cannot predict where these changes will take us, but we can use this knowledge to get fit and ready to play our role in meeting the energy needs of tomorrow," said Bob Dudley, group chief executive.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
PG&E agreed to pay around $13.5 billion to settle all individual claims related to California wildfires, due to which the electric utility had to file for bankruptcy. With the Bankruptcy Court's approval of the settlement agreement, PG&E hopes to emerge from Chapter 11 by the June 30, 2020 deadline to participate in the State of California's go-forward wildfire fund. Airbnb has introduced few new rules to control parties and nuisances amidst the backlash the service received after the Halloween shooting at an Airbnb rental in a San Francisco. San Francisco-based Airbnb said it is banning "open invite" parties at all of its accommodations. The company is also banning... The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director...
Follow RTT
>